We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

First Patients Screened for Phase 2B Studies with GLPG0634

News   Jul 01, 2013

 
First Patients Screened for Phase 2B Studies with GLPG0634
 
 
Advertisement
 

RELATED ARTICLES

FDA Approves Remdesivir for COVID-19

News

The US Food and Drug Administration has approved the antiviral drug Veklury (remdesivir) for use in adult and pediatric patients (≥ 12 years of age and weighing at least 40 kg) for the treatment of COVID-19 requiring hospitalization.

READ MORE

UK Researchers Set To Explore Human Challenge Studies for COVID-19 Vaccine Development

News

Researchers are set to explore a human challenge study with the virus that causes COVID-19, the first such study anywhere in the world.

READ MORE

Glutathione Precursor Improves Conditions Associated With Premature Aging in HIV Patients

News

An open-label clinical trial found that a glutathione precursor, GlyNAC, reverses premature aging in people with HIV.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE